{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:04:48Z","timestamp":1759482288053},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s11899-009-0032-3","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T07:16:19Z","timestamp":1254294979000},"page":"245-252","source":"Crossref","is-referenced-by-count":22,"title":["Natural killer-cell neoplasms"],"prefix":"10.1007","volume":"4","author":[{"given":"John P.","family":"Greer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio A.","family":"Mosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,1]]},"reference":[{"key":"32_CR1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/0046-8177(92)90350-C","volume":"23","author":"K.F. Wong","year":"1992","unstructured":"Wong KF, Chan JK, Ng CS, et al.: CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous\/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 1992, 23:798\u2013804.","journal-title":"Hum Pathol"},{"key":"32_CR2","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J. Armitage","year":"2008","unstructured":"Armitage J, Vose J, Weisenburger D: International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008, 26:4124\u20134130.","journal-title":"J Clin Oncol"},{"key":"32_CR3","first-page":"285","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"J.K.C. Chan","year":"2007","unstructured":"Chan JKC, Quintanill-Martinez L, Ferry JA, Peh SC: Extranodal NK\/T-cell lymphoma, nasal type. In WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Edited by Swerdlow SH, Campo E, Harris NL, et al. Lyon, France: International Agency for Research on Cancer (IARC); 2007:285\u2013288."},{"key":"32_CR4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hon.847","volume":"26","author":"R. Suzuki","year":"2008","unstructured":"Suzuki R, Takeuchi K, Ohshima K, et al.: Extranodal NK\/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol 2008, 26:66\u201372.","journal-title":"Hematol Oncol"},{"key":"32_CR5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"M.A. Caligiuri","year":"2008","unstructured":"Caligiuri MA: Human natural killer cells. Blood 2008, 112:461\u2013469.","journal-title":"Blood"},{"key":"32_CR6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/cncr.23316","volume":"112","author":"X. Liang","year":"2008","unstructured":"Liang X, Graham DK: Natural killer cell neoplasms. Cancer 2008, 112:1425\u20131436.","journal-title":"Cancer"},{"key":"32_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1309\/FY6PK436NBK0RYD4","volume":"127","author":"M. Herling","year":"2007","unstructured":"Herling M, Jones D. CD4+\/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol 2007, 127:687\u2013700.","journal-title":"Am J Clin Pathol"},{"key":"32_CR8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","volume":"127","author":"R.P. Hasserjian","year":"2007","unstructured":"Hasserjian RP, Harris NL: NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol 2007, 127:860\u2013868.","journal-title":"Am J Clin Pathol"},{"key":"32_CR9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/MN4Y8HLQWKD9NB5E","volume":"128","author":"P.P. Hsieh","year":"2007","unstructured":"Hsieh PP, Tung CL, Chan AB, et al.: EBV viral load in tumor tissue is an important prognostic indicator for nasal NK\/T-cell lymphoma. Am J Clin Pathol 2007, 128:579\u2013584.","journal-title":"Am J Clin Pathol"},{"key":"32_CR10","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","volume":"157","author":"L. Siu","year":"2000","unstructured":"Siu L, Chan V, Chan J, et al.: Consistent patterns of allelic loss in natural killer cell lymphoma. Am J Pathol 2000, 157:1803\u20131809.","journal-title":"Am J Pathol"},{"key":"32_CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10428199909050949","volume":"34","author":"K.F. Wong","year":"1999","unstructured":"Wong KF, Zhang YM, Chan JK: Cytogenetic abnormalities in natural killer cell lymphoma\/leukaemia\u2014is there a consistent pattern? Leuk Lymphoma 1999, 34:241\u2013250.","journal-title":"Leuk Lymphoma"},{"key":"32_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","volume":"44","author":"Y. Nakashima","year":"2005","unstructured":"Nakashima Y, Tagawa H, Suzuki R, et al.: Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK\/T-cell lymphoma, nasal type. Genes Chromosomes Cancer 2005, 44:247\u2013255.","journal-title":"Genes Chromosomes Cancer"},{"key":"32_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/hupa.2001.21569","volume":"32","author":"B. Petit","year":"2001","unstructured":"Petit B, Leroy K, Kanavaros P, et al.: Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations. Hum Pathol 2001, 32:196\u2013204.","journal-title":"Hum Pathol"},{"key":"32_CR14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12185-008-0021-7","volume":"87","author":"K. Aozasa","year":"2008","unstructured":"Aozasa K, Takakuwa T, Hongyo T, et al.: Nasal NK\/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol 2008, 87:110\u2013117.","journal-title":"Int J Hematol"},{"key":"32_CR15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2003.08.025","volume":"35","author":"M. Takahara","year":"2004","unstructured":"Takahara M, Kishibe K, Bandoh N, et al.: P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK\/T-cell lymphoma from Hokkaido, Japan. Hum Pathol 2004, 35:86\u201395.","journal-title":"Hum Pathol"},{"key":"32_CR16","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1349-7006.2001.tb01059.x","volume":"92","author":"S. Sakajiri","year":"2001","unstructured":"Sakajiri S, Kawamata N, Egashira M, et al.: Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms. Jpn J Cancer Res 2001, 92:1048\u20131056.","journal-title":"Jpn J Cancer Res"},{"key":"32_CR17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-0609.2005.00417.x","volume":"74","author":"N. Kawamata","year":"2005","unstructured":"Kawamata N, Inagaki N, Mizumura S, et al.: Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1\/Cip1, p27Kip1 and p73) in natural killer cell disorders. Eur J Haematol 2005, 74:424\u2013429.","journal-title":"Eur J Haematol"},{"key":"32_CR18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1349-7006.2006.00226.x","volume":"97","author":"A. Liu","year":"2006","unstructured":"Liu A, Takakuwa T, Luo WJ, et al.: Alterations in ATR in nasal NK\/T-cell lymphoma and chronic active Epstein-Barr virus infection. Cancer Sci 2006, 97:605\u2013610.","journal-title":"Cancer Sci"},{"key":"32_CR19","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"W.Y. Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T, et al.: Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009, 113:3931\u20133937.","journal-title":"Blood"},{"key":"32_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2006.03.014","volume":"79","author":"K. Sakata","year":"2006","unstructured":"Sakata K, Fuwa N, Kodaira T, et al.: Analyses of dose-response in radiotherapy for patients with mature T\/NK-cell lymphomas according to the WHO classification. Radiother Oncol 2006, 79:179\u2013184.","journal-title":"Radiother Oncol"},{"key":"32_CR21","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ejca.2005.03.010","volume":"41","author":"J. Lee","year":"2005","unstructured":"Lee J, Park YH, Kim WS, et al.: Extranodal nasal type NK\/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005, 41:1402\u20131408.","journal-title":"Eur J Cancer"},{"key":"32_CR22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J. Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, et al.: Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006, 24:612\u2013618.","journal-title":"J Clin Oncol"},{"key":"32_CR23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.21256","volume":"83","author":"B. Wang","year":"2008","unstructured":"Wang B, Li XQ, Ma X, et al.: Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK\/T-cell lymphoma, nasal type. Am J Hematol 2008, 83:795\u2013799.","journal-title":"Am J Hematol"},{"key":"32_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10245330701214327","volume":"12","author":"A. Aviles","year":"2007","unstructured":"Aviles A, Cleto S, Castaneda C, et al.: CMED in the treatment of nasal natural killer cell lymphoma with distant metastases. Hematology 2007, 12:241\u2013244.","journal-title":"Hematology"},{"key":"32_CR25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1349-7006.2008.00768.x","volume":"99","author":"M. Yamaguchi","year":"2008","unstructured":"Yamaguchi M, Suzuki R, Kwong YL, et al.: Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia. Cancer Sci 2008, 99:1016\u20131020.","journal-title":"Cancer Sci"},{"key":"32_CR26","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1200\/JCO.2009.23.8295","volume":"27","author":"M. Yamaguchi","year":"2009","unstructured":"Yamaguchi M, Tobinai K, Oguchi Y, et al.: Phase VII study of concurrent chemoradiotherapy for localized nasal NK\/Tcell lymphoma: Final results of JCOGO211 [abstract 8549]. J Clin Oncol 2009, 27:4465.","journal-title":"J Clin Oncol"},{"key":"32_CR27","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2001.19.8.2179","volume":"19","author":"S. Mraz-Gernhard","year":"2001","unstructured":"Mraz-Gernhard S, Natkunam Y, Hoppe RT, et al.: Natural killer\/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001, 19:2179\u20132188.","journal-title":"J Clin Oncol"},{"key":"32_CR28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","volume":"18","author":"R. Suzuki","year":"2004","unstructured":"Suzuki R, Suzumiya J, Nakamura S, et al.: Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004, 18:763\u2013770.","journal-title":"Leukemia"},{"key":"32_CR29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/107327480701400207","volume":"14","author":"T.J. Alekshun","year":"2007","unstructured":"Alekshun TJ, Sokol L. Diseases of large granular lymphocytes. Cancer Control 2007, 14:141\u2013150.","journal-title":"Cancer Control"},{"key":"32_CR30","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63373-1","volume":"165","author":"M. Lima","year":"2004","unstructured":"Lima M, Almeida J, Montero AG, et al.: Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-\/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 2004, 165:1117\u20131127.","journal-title":"Am J Pathol"},{"key":"32_CR31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.bbmt.2008.09.014","volume":"14","author":"J. Lee","year":"2008","unstructured":"Lee J, Au WY, Park MJ, et al.: Autologous hematopoietic stem cell transplantation in extranodal natural killer\/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant 2008, 14:1356\u20131364.","journal-title":"Biol Blood Marrow Transplant"},{"key":"32_CR32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05651.x","volume":"130","author":"N. Murashige","year":"2005","unstructured":"Murashige N, Kami M, Kishi Y, et al.: Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 2005, 130:561\u2013567.","journal-title":"Br J Haematol"},{"key":"32_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705244","volume":"37","author":"R. Suzuki","year":"2006","unstructured":"Suzuki R, Suzumiya J, Nakamura S, et al.: Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006, 37:425\u2013431.","journal-title":"Bone Marrow Transplant"},{"key":"32_CR34","doi-asserted-by":"crossref","first-page":"122a","DOI":"10.1182\/blood.V108.11.122.122","volume":"108","author":"O.A. O\u2019Conner","year":"2006","unstructured":"O\u2019Conner OA, Hamlin PA, Gerecitano J, et al.: Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-cell lymphomas: results of the MSKCC phase I\/II experience. Blood 2006, 108:122a\u2013123a.","journal-title":"Blood"},{"key":"32_CR35","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/1078-0432.CCR-07-4262","volume":"14","author":"L. Ellis","year":"2008","unstructured":"Ellis L, Pan Y, Smyth GK, et al.: Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma. Clin Cancer Res 2008, 14:4500\u20134510.","journal-title":"Clin Cancer Res"},{"key":"32_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2008.07284.x","volume":"143","author":"G. Packham","year":"2008","unstructured":"Packham G: The role of NF-kappaB in lymphoid malignancies. Br J Haematol 2008, 143:3\u201315.","journal-title":"Br J Haematol"},{"key":"32_CR37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/labinvest.3700291","volume":"85","author":"Y.K. Jeon","year":"2005","unstructured":"Jeon YK, Kim H, Park SO, et al.: Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK\/T-cell lymphoma. Lab Invest 2005, 85:874\u2013884.","journal-title":"Lab Invest"},{"key":"32_CR38","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1182\/blood-2008-02-136382","volume":"112","author":"P.K. Epling-Burnette","year":"2008","unstructured":"Epling-Burnette PK, Sokol L, Chen X, et al.: Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling. Blood 2008, 112:4694\u20134698.","journal-title":"Blood"},{"key":"32_CR39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2009.07606.x","volume":"145","author":"L. Jiang","year":"2009","unstructured":"Jiang L, Yuan C, Hubacheck J, et al.: Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy. Br J Haematol 2009, 145:173\u2013179.","journal-title":"Br J Haematol"},{"key":"32_CR40","first-page":"899","volume":"6","author":"A.A. Alizadeh","year":"2008","unstructured":"Alizadeh AA, Advani RH: Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies. Clin Adv Hematol Oncol 2008, 6:899\u2013909.","journal-title":"Clin Adv Hematol Oncol"},{"key":"32_CR41","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1158\/1078-0432.CCR-08-1254","volume":"15","author":"D. O\u2019Mahony","year":"2009","unstructured":"O\u2019Mahony D, Morris J, Stetler-Stevenson M, et al.: EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies. Clin Cancer Res 2009, 15:2514\u20132522.","journal-title":"Clin Cancer Res"},{"key":"32_CR42","doi-asserted-by":"crossref","first-page":"194b","DOI":"10.1182\/blood.V110.11.4492.4492","volume":"110","author":"N. Uike","year":"2007","unstructured":"Uike N, Tsukasaki K, Utsunomiya A, et al.: Phase I study of KW-0761, a humanized anti-CCR4 antibody in patients (pts) with relapsed or refractory adult T-cell leukemialymphoma (ATLL) and peripheral T-cell lymphoma (PTCL) preliminary results [abstract 4492]. Blood 2007, 110:194b.","journal-title":"Blood"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-009-0032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-009-0032-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-009-0032-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T16:24:46Z","timestamp":1590164686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-009-0032-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s11899-009-0032-3","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}